Clinical and Practical Psychopharmacology

Clinical and Practical Psychopharmacology

Famotidine Augmentation in Schizophrenia: Hope or Hype?

September 15, 2013

Clinical and Practical Psychopharmacology

Levothyroxine in Psychiatry: Issues Related to Absorption After Oral Dosing

August 15, 2013

Clinical and Practical Psychopharmacology

Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Duration of Gestation

July 15, 2013

Clinical and Practical Psychopharmacology

Low-Dose Amisulpride and Elevation in Serum Prolactin

June 15, 2013

Clinical and Practical Psychopharmacology

Signal-to-Noise Ratio, Variability, and Their Relevance in Clinical Trials

May 15, 2013

Clinical and Practical Psychopharmacology

Antidepressant Action of Atypical Antipsychotics: Focus on Ziprasidone Monotherapy, With a Few Twists in the Tale

March 15, 2013

Clinical and Practical Psychopharmacology

Augmentation of Venlafaxine With Bupropion: Risks Associated With a Triple Monoamine Reuptake Inhibition Approach to Partially Responsive Depression

February 15, 2013

Clinical and Practical Psychopharmacology

Drug Interactions in the Treatment of Depression in Patients Receiving β-Blocker Drugs

January 15, 2013

Clinical and Practical Psychopharmacology

Drug Interactions in the Treatment of Depression in Patients With Ischemic Heart Disease

December 15, 2012

Clinical and Practical Psychopharmacology

Serotonin Reuptake Inhibitor Treatment of Obsessive-Compulsive Symptoms in Clozapine-Medicated Schizophrenia

November 15, 2012

Clinical and Practical Psychopharmacology

There’s More to Placebo-Related Improvement Than the Placebo Effect Alone

October 15, 2012

Clinical and Practical Psychopharmacology

Breast Cancer and Antidepressant Use

September 15, 2012